BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//GÉTICA, Grupo Español de Terapias Inmuno-Biológicas en Cáncer//NO
 NSGML kigkonsult.se iCalcreator 2.30.10//
CALSCALE:GREGORIAN
METHOD:PUBLISH
UID:f22a3498-a9e5-42d0-b297-59166582fe8d
X-WR-CALNAME:iCagenda
X-WR-CALDESC:Event Management Extension for Joomla!
X-WR-RELCALID:3E26604A-50F4-4449-8B3E-E4F4932D05B5
X-WR-TIMEZONE:Europe/Madrid
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:STANDARD
TZNAME:CET
DTSTART:20171029T030000
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
RDATE:20181028T030000
RDATE:20191027T030000
END:STANDARD
BEGIN:DAYLIGHT
TZNAME:CEST
DTSTART:20180325T020000
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
RDATE:20190331T020000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:da86f32b-8f53-47b1-b219-5ab741c1033e
DTSTAMP:20260504T005859Z
CATEGORIES:GÉTICA
CLASS:PUBLIC
DESCRIPTION;ALTREP="CID:<FFFF__=0ABBE548DFE235B58f9e8a93d@coffeebean.com>":
 The European Congress on Immunotherapies in Cancer™ is a 2-day comprehensi
 ve and interactive program focused exclusively on immunotherapies and thei
 r practical application to the management of cancer. This intensive\, inte
 ractive program will provide you with a comprehensive review of key data s
 ets that are most relevant for managing some of the most difficult-to-trea
 t forms of cancer. The program will focus on scientific advances\, recent 
 clinical trial results that&nbsp\; shape current and evolving uses of thes
 e approaches\, proactive methods to monitor and&nbsp\; mitigate treatment-
 related adverse events\, current and emerging testing methods\,&nbsp\; and
  multidisciplinary team approaches to optimize the use of immunotherapeuti
 c strategies to treat cancer.\n\nPresentación de comunicaciones\n
DTSTART:20180921T070000Z
DTEND:20180922T120000Z
GEO:+41.389137;+2.132987
LOCATION:Hilton Barcelona
ORGANIZER:
SEQUENCE:1
SUMMARY:3rd Annual European Congress on Immunotherapies in Cancer
TRANSP:OPAQUE
URL:https://getica.org/component/icagenda/12-3rd-annual-european-congress-o
 n-immunotherapies-in-cancer
END:VEVENT
END:VCALENDAR